NASDAQ
Aligos Therapeutics, Inc. (ALGS) has a free cash flow growth of -6.23% as of Friday, May 29, 2026. This represents a 27.48% increase compared to its 12-month average of -8.59%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.